Introduction
Fetal cardiac development is regulated by various ge- netic and environmental influences. Aberrations in these developmental mechanisms result in structural and functional abnormalities of the fetal heart. There has been a greater recognition of the need for ante- partum diagnosis of these disorders in recent years.
Perinatal diagnosis and management of congenital cardiac disease in conjunction with advances in pe- diatric cardiac surgery has led to remarkable im- provements in the outcome in these infants. An es- sential component of this approach is the reliable pre- natal diagnosis, which permits planning and imple- mentation of appropriate perinatal management.
Although high-resolution two-dimensional (2D) dy- namic imaging remains the foundation of fetal echo- cardiographic assessment, the Doppler modality con- stitutes an essential component of this process by providing hemodynamic insight into the morphologic and functional aberrations of the fetal heart. With the advent of real-time three-dimensional (3D) echocar- diography, there are exciting possibilities for prenatal cardiac assessment including Doppler echocardiogra- phy. In the previous chapter, we reviewed the scope and technique of Doppler echocardiography and nor- mative information on fetal cardiac hemodynamics, while the next chapter, which is a new addition to this edition, deals with real-time 3D echocardiogra- phy of the human fetus. In this chapter, we review the risk factors for congenital cardiac disease, the common indications for fetal cardiac evaluation, and the application of Doppler echocardiography in man- aging malformations and dysrhythmias of the fetal heart.
Risk Factors and Indications for Fetal Cardiac Evaluation
Congenital cardiac disease, as diagnosed clinically, has a prevalence of approximately 8 cases per 1,000 live births [1]. The rate of critical cardiac malforma- tions requiring early therapeutic and surgical inter-
vention has been reported to be 3.5 per 1,000 live births [2]. The risk of cardiac malformations is in- creased in many conditions (Table 33.1). When these risk factors are present, prenatal counseling and diag-
Doppler Echocardiography
for Managing Congenital Cardiac Disease
Dev Maulik
Table 33.1. Risk factors for congenital heart disease Familial
History of congenital cardiac disease Genetic syndromes (Mendelian)
Noonan
Tuberosus sclerosis Marfan
Holt-Oran
TAR (thrombocytopenia with absent radii) Maternal
Congenital heart disease Teratogenic exposure
Anticonvulsants ± phenytoin, trimethadione, valproic acid Lithium
Amphetamines Retinoic acid Alcohol
Nonteratogenic exposure Indomethacin
Maternal infection
Viral ± rubella, cytomegalovirus, coxsackievirus, mumps Parasitic ± toxoplasmosis
Metabolic disease Diabetes mellitus Phenylketonuria Autoimmune disease Obstetrical
Polyhydramnios Fetal
Suspicion of cardiac malformation in basic fetal scan Abnormal fetal cardiac rhythm
Extracardiac malformation Increased nuchal translucency Chromosomal disorders
Down's syndrome
Trisomy 13, 18
Turner's syndrome
Genetic syndromes
Fetal growth restriction
Nonimmune hydrops
Situs inversus and ambiguous
nostic procedures should be offered to the mother.
Recently, increased nuchal translucency at 10±14 weeks of gestation in chromosomally normal fetuses has emerged as an indication because of its associa- tion with cardiac malformations. The extent of this association varies between 7% and 9% [3, 4]. Contro- versy, however, exists on whether polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR) lead to a higher risk of congenital cardiac defect [5, 6], and it therefore remains uncertain whether this abnormality should indicate fetal cardiac evaluation.
Although a precise measure of the increased risk is not available for all the conditions listed in Table 33.1, a summary of risk quantification for selected conditions is presented in Table 33.2. Such informa- tion should be an essential part of informed counsel- ing of patients. More detailed information may be ob- tained from the standard texts on pediatric cardiol- ogy. Fetal echocardiography is indicated whenever a higher probability of fetal cardiac malformation ex- ists. It is also indicated for the precise diagnosis and follow-up of fetal cardiac arrhythmias and fetal heart failure. Furthermore, a suspicious fetal cardiac image during general obstetrical ultrasonography mandates more focused assessment. In many centers, a non-re- assuring fetal cardiac image is the most common rea- son for echocardiographic referral. Frequency of these indications varies from center to center. Com- mon indications for fetal echocardiography are listed in Table 33.3.
Benefits of Fetal Echocardiographic Assessment
Fetal echocardiographic examination allows prenatal diagnosis of congenital heart disease so that appro- priate perinatal management can be planned and im- plemented. An accurate diagnosis of the cardiac le- sion will obviously lead to more reliable prognostica- tion and informed management choices. The process involves participation by a multidisciplinary perinatal cardiology team which should include primary ob- stetricians, maternal-fetal medicine specialists, neona- tologists, pediatric cardiologists, cardiac surgeons, and other relevant support personnel. In addition, the parents must be an integral part of this process so that they are appropriately counseled regarding the fetal condition and prognosis, and are able to partici- pate in the decision-making process. In early gesta- tion, severe cardiac anomalies with poor prognosis may prompt the parents to opt for a termination of pregnancy. If this is not an option, a multidisciplin- ary medical team can develop optimal plans for sur- veillance, delivery, and perinatal intervention. Table 33.4 summarizes the prognostic factors for survival.
Depending on the complexity of the fetal cardiac problem, the site for delivery and neonatal manage- ment can be carefully selected. This is particularly important as not all medical centers may have ade- quate medical or surgical resources to deal effectively with the complexities of congenital heart disease. In this context, one should also note that recent progress in surgical management of certain malformations has improved the chances of survival in cases previously considered hopeless [7]. The reported mortality rate following pediatric cardiac surgery in one of the prominent centers is given in Table 33.5. As noted during the 32nd Bethesda Conference, ªCare Of The Adult With Congenital Heart Diseaseº, the survival rate has continued to improve over the last few de- cades and the estimated cumulative survivors of con- Table 33.2. Approximate risk of cardiac anomalies for se-
lected high risk conditions
Anomaly Risk (%)
Isolated cardiac anomalies (multifactorial)
Overall 3±5
Mother 10
Father 3±5
Sibling 3
Left heart anomalies 10±15
Environmental
Maternal rubella infection 35
Pregestational diabetes 3±5
Phenylketonuria (phenylalanine > 16 mg/dl) 18
Alcohol consumption 25±30
Trimethadone 15±30
Retinoic acid 4
Genetic
Overall 25
Marfan syndrome 60±80
Holt-Oram syndrome 100
Chromosomal
Overall 25
Trisomy 21 50
Trisomy 18 100
Data are derived from the literature.
Table 33.3. Indications for fetal echocardiographic assess- ment
n Non-reassuring fetal cardiac image during obstetrical sonography
n Extracardiac malformations n Fetal cardiac arrhythmia n Increased nuchal translucency
n Insulin-dependent diabetes mellitus in pregnancy n History of congenital cardiac disease
n Teratogenic exposure
n Maternal viral infection
n Nonimmune hydrops
n Nonlethal aneuploidy
genital heart disease to the year 2000 in the United States approached almost 800,000 [8]. An additional emerging benefit of prenatal diagnosis of congenital heart disease may be the potential for in utero inter- vention for congenital structural cardiac disease, which has been investigated in animal models [9, 10].
Preliminary anecdotal accounts of human fetal cardi- ac interventions have been reported in the medical press [11]. Although they are still experimental approaches at present, future advances may transform these approaches into clinical realities. Obviously fetal echocardiography including Doppler sonography will continue to play a critical role in any such develop- ment. This is further discussed below.
Utility of Fetal Doppler
Echocardiographic Assessment
The importance of Doppler echocardiography lies in the fact that it allows noninvasive assessment of car- diovascular hemodynamic function. Both modalities of Doppler ultrasound offer significant advantages in supplementing the diagnostic information obtained from the 2D echocardiography. However, the opera- tors should be appropriately trained to use the device optimally. The advantages and disadvantages of Dop- pler echocardiography are summarized in Table 33.6.
Spectral Doppler insonation, used in conjunction with the other ultrasound modalities, allows the mea- surement of peak or mean velocity, which may be uti- lized to define the normal and the abnormal blood flow characteristics. Almost two decades ago, the di- agnostic potential of duplex spectral pulsed Doppler and color Doppler echocardiography was demon- strated in recognizing fetal cardiac abnormalities such as pulmonary arterial aneurysm and tricuspid regurgitation [12, 13]. As reviewed in this chapter, numerous extensive investigations subsequently con- firmed the utility of these approaches. Chiba and as- sociates [14] noted the usefulness of color flow map- ping for identifying congenital cardiac malformations in 107 high-risk mothers, about a third of whom had cardiac disease. Fetal cardiac malformations were pre- sent in 19 cases and included complex disorders. Co- pel and associates [15] used color Doppler in 45 of 48 fetuses with cardiac anomalies and noted that col- or flow mapping was essential for making correct anatomical diagnoses in almost a third of the cases.
Over time, the technique has proved useful in defin- ing structural, functional, and hemodynamic anoma- lies of the fetal heart. Color Doppler facilitates the recognition of anomalies, especially when they are not clearly defined in 2D imaging, and may reduce the examination time. Furthermore, spectral and col- or Doppler modes are essential for identifying abnor- mal flow patterns associated with valvular incompe- tence or stenotic lesions of the vascular channels.
In Utero Evolution
of Cardiac Malformations
Experience with fetal echocardiographic examination over the years has revealed the dynamics of in utero evolution of fetal cardiac disease [16]. In addition to the structural defects, functional changes in the fetal heart can also be observed secondary to various disor- ders including viral infection and rhythm disturbances.
Allan and associates were one of the first groups [17] to Table 33.4. Survival after surgery in the presence of con-
genital heart disease: Boston Children's Hospital
Anomaly Time of
surgery Early mortality
%
Late mortality
% AVcanal defect 1976±1987 2.9
Ventricular septal
defect 1984±1990 0 0
Fallot's tetralogy 1985±1990 2.5 0 Ebstein's anomaly 1982±1990 17.0 11 Left heart hypoplasia
syndrome 1984±1985 24.0 17
D